Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Licenses OGT's Array IP, Companies Ink Supply Agreement

NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed patents covering its oligonucleotide array technology to NimbleGen, based in Madison, Wisc., the companies said today.
 
The companies have also signed a supply agreement under which OGT will have access to NimbleGen’s DNA microarrays for use in its services business. NimbleGen will also be able to make and sell OGT-designed arrays.
 
Financial terms of the agreements were not released.
 
This is the second agreement that NimbleGen has recently signed for fundamental array IP. In October, the company licensed the rights to Affymetrix’s microarray patents.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.